EVALUATION OF THREE MEDICINAL PLANT EXTRACTS AGAINST PLASMODIUM FALCIPARUM AND SELECTED MICROGANISMS by Falodun, Abiodun et al.
Falodun et al., Afr J Tradit Complement Altern Med. (2014) 11(4):142-146
http://dx.doi.org/10.4314/ajtcam.v11i4.22
142
EVALUATION OF THREE MEDICINAL PLANT EXTRACTS AGAINST PLASMODIUM FALCIPARUM AND
SELECTED MICROGANISMS
Abiodun Falodun1, 3*, Vincent Imieje1, 2, Osayewenre Erharuyi1, 2, Joy Ahomafor1, Melissa R. Jacob4, Shabana I.
Khan4 and Mark T. Hamann3
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, Nigeria.
2Institute of Organic Chemistry, University of Restock, 18509, Restock, Germany.
3Department of Pharmacognosy, School of Pharmacy, University, University of Mississippi, MS 38655, USA.
4Center for for Natural Products Research, School of Pharmacy, University of Mississippi, MS, 38677, USA.
*E-mail: abiodun.falodun@fulbrightmail.org, faloabi@uniben.edu
Abstract
Background: A great revival of scientific interests in drug discovery has been witnessed in recent years from medicinal plants for health maintenance.
The aim of this work was to investigate three Nigerian medicinal plants collected in Nigeria for their in vitro antiplasmodial and antimicrobial
activities.
Materials and Methods: Extracts obtained from parts of Persea americana, Jatropha podagrica and Picralima nitida and their fractions were
evaluated for in vitro antiprotozoal and antimicrobial activity.
Result: The methanol extract of P. nitida demonstrated activity against chloroquine-sensitive and chloroquine-resistant P. falciparum clones with IC50
values of 6.3 and 6.0 µg/mL, respectively. Methanol and chloroform extracts of P. americana seed showed antifungal activity against Cryptococcus
neoformans IC50 less than 8 and 8.211 µg/mL respectively. Finally, the petroleum ether extract of P. americana had activity against methicillin-
resistant Staphylococcus aureus (MRSA) with an IC50 value of 8.7 µg/mL.
Conclusion: The study revealed the antibacterial and antiplasmodial activities of the plants extracts at the tested concentrations.
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Introduction
Parasitic diseases such as malaria have a high mortality rate having a significant impact in developing countries and affecting several
hundred millions of people worldwide. Malaria is one of the most important parasitic diseases in the world and is a major global health problem
affecting over one hundred countries with disease prevalence escalating at an alarming rate, particularly in the last two decades. Rapid development of
resistance by Plasmodium falciparum to the conventional drugs such as chloroquine necessitates the search for new antimalarials (Iwu et al., 1994;
Wolf, 2002; Guerin et al., 2002; Fournet and Munoz, 2002). Malaria, a devastating infectious disease caused by highly adaptable protozoan parasites
of the genus Plasmodium, has impacted on humans for more than 4000 years, causing illness and an estimated 1.5–2.5 million deaths each year.
Malaria is endemic throughout the tropics, especially in sub-Saharan Africa and the developing world, threatening about 40 % of the world’s
population. Although four Plasmodium parasite species can infect humans, Plasmodium falciparum causes the majority of illnesses and deaths. Severe
malaria, deﬁned as acute malaria with major signs of organ dysfunction or high levels of parasitemia, predominantly affects children and pregnant 
women (Piece and Miller, 2009; Rosenthal, 2008; White, 2008).
Chemotherapy is still at the forefront in the ﬁght against malaria due to the unavailability of effective vaccines. Numerous drugs have been
developed for the treatment of uncomplicated malaria, for example, meﬂoquine, primaquine, quinidine, proguanil (Genton, 2008; Vekemans and 
Ballon, 2005).There is still need to search for newer and novel antimalarial agents from natural products via ethnopharmacological approach.
Similarly, an increasing number of multidrug-resistant microbial pathogens have become a serious problem particularly during the last decade and
provide the impetus for the search and discovery of novel antibacterial and antifungal agents active against these pathogens (Liu and
Balasubramanian, 2001).
Picralima nitida is a tree or shrub belonging to the family Apocynaceae. It is widely distributed in high deciduous forest of West and Central
Africa. It is employed in African traditional medicine as antipyretic, antimalarial, aphrodisiac and for GIT disorders (Wosu and Ibe, 1989).
Jatropha podagrica Hook is a shrub grown in West Africa gardens for its showy red flowers. It is known locally in south western Nigeria as lapalapa
funfun. Jatropha species are found in Africa, Asia and Latin America where they are used in folk medicine to treat various diseases including parasitic
skin infections, hepatitis and sexually transmitted diseases (Aiyelaagbe et al., 2002; Sanni et al., 1988; Schmeda-Hirschmann et al., 1992). Various
medicinal and pesticidal properties including antibacterial (pneumonia), antitumor and insect antifeedant have been attributed to this plant (Odebiyi,
1980). Phytochemicals in different parts of the plants includes flavonoids, steroids, alkaloids and diterpenoids have been isolated and characterized
(Aiyelaagbe et al., 2007, 1998; Das and Venkatail, 2006).
Persea americana Mill commonly known as ‘avocado pear’ is a medium-sized, single-stemmed, terrestrial, erect, perennial, deciduous,
evergreen tree of 15 – 20 m in height. The leaves and other morphological parts of P. americana possess medicinal properties, and are widely used in
traditional medicines of many African countries as antitussive, antimicrobial, antidiabetic, antiparasitic, anti allergic, antihypertensive, analgesic and
anti-inflammatory remedies (Adeyemi et al., 2002; Antia et al., 2005; Adeboye et al., 1999; Owolabi et al., 2005).
In this study, extracts of different parts of P. americana were evaluated for the first time for antifungal and antibacterial activities. The methanol
extract and fractions of P. nitida against two strains of Plasmodium falciparum were determined.
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Materials and Methods
Plant materials
All Plant material (Table 1) was collected from Ovia North east, Owan east and Benin City, all in Edo State, Nigeria between January and
June, 2013. They were identified and authenticated by Mr. Ugbogu O. A. and Shasanya O. S. of the Forest Research Institute of Nigeria (FRIN),
Ibadan where voucher specimens is deposited in the Herbarium (Table 1).
Preparation of extracts
The powdered (100 g) material of each sample was extracted with 500 ml methanol for 48 hr ( 3 X ) by cold maceration, filtered and the
filtrate evaporated to dryness to obtained crude extract of P. nitida (PNS), J. podagrica fruit (JPF), P. americana root (PAR), P. americana seed
(PAS ) and chloroform fraction of P. americana seed (PASC). The dried extracts and fractions were each screened for antiplasmodial and
antimicrobial activities. The fractions PN1, PN2, PN3, PN4 and PN5 are hexane: ethylacetate 50 %, ethylacetate 100 %, hexane: ethylacetate 80 %,
methanol 100 % and alkaloidal mixture respectively, were obtained from the vacuum liquid chromatography (VLC) with normal silica and the
solvents.
Antimicrobial testing
In vitro antimicrobial activity against a panel of microorganisms, including fungi: Candida albicans (ATCC 90028), Candida glabrata
(ATCC 90030), Candida krusei (ATCC 6258), C. neoformans (ATCC 90113) and Aspergillus fumigatus (ATCC 204305); and bacteria:
Staphylococcus aureus (ATCC 29213), methicillin-resistant S. aureus (MRSa) (ATCC 33591), Escherichia coli (ATCC 35218), Pseudomonas
aeruginosa (ATCC 27853) and Mycobacterium intracellulare (ATCC 23068), was determined using modiﬁed versions of the CLSI/NCCLS methods 
(NCCL, 2000; NCCL, 2002). M. intracellulare and A. fumigatus was tested using an Alamar Blue method (Franzblau et al., 1998). All organisms were
obtained from the American Type Culture Collection (Manassas, VA). Samples, dissolved in DMSO, were serially diluted in saline and transferred in
duplicate to 96 well micro plates. Susceptibility testing was performed for all organ cate to 96-well ﬂat bottom micro plates. Microbial inocula were 
prepared by correcting the OD630 of microbe suspensions in incubation broth to afford ﬁnal target inocula. Controls [fungi: amphotericin B; bacteria: 
ciproﬂoxacin (ICN Biomedicals, OH)] were included in each assay. All plates were read at 530 or 544(ex)/590(em) nm (M. intracellulare and A.
fumigatus) prior to and after incubation. Percent growth was plotted versus test concentration to afford the IC50 using XLFit (Alameda, CA).
Antimalarial/Parasite LDH Assay
The in vitro antimalarial assay procedure utilized was an adaptation of the parasite lactate dehydrogenase (pLDH) assay developed by
Makler et al., 1993.The assay was performed in a 96-well microplate and included two P. falciparum clones [Sierra Leone D6 (chloroquine-sensitive)
and Indochina W2 (chloroquine- resistant)]. In primary screening the crude plant extracts were tested, in duplicate, at a single concentration of 15.9
íg/mL only on the chloroquine-sensitive (D6) strain of P. falciparum. The extract showing >50 % growth inhibition of the parasite was subjected to
screening. For bioassay-guided fractionation, the column fractions were also tested only at single concentration. The pure compounds were subjected
to additional testing for determination of IC50 values. The standard antimalarial agents chloroquine and artemisinin were used as positive controls,
with DMSO (0.25 %) as the negative (vehicle) control. The selectivity indices (SI) were determined by measuring the cytotoxicity of samples on
mammalian cells (VERO; monkey kidney fibroblast). All experiments were carried out in duplicate.
Results
Air-dried parts of the plants tested were pulverized, extracted and the percentage yield calculated as shown in Table 1. The percentage yield
of 11.25, 3.45, 40.68 and 12.85 were obtained for P. nitida, PNS1, PNS5, P. americana root and PAS, respectively.
The antibacterial and antifungal activities of P. americana and Jatropha podagrica against a panel of organisms are shown in Tables 2 and 3. The
results showed that the plant extracts were effective against both bacterial and fungal organisms. The plant extracts showed different antimicrobial
activity (IC50 values) to the test organisms. The methanol extract of Persea americana seed (PAS) showed activity against all the bacterial and fungal
isolates. A very good activity was observed against C. neoformans at IC50 value of 8 µg/mL. The chloroform fraction (PASC) also exhibited high
inhibitory activity against C. neoformans (Tables 2 and 3).
The antimalarial activity of Picralima nitida total extract and fractions against two strains of Plasmodium falciparum demonstrated high
inhibitory activity against the two species (Table 4).
Discussion
The current study was carried out on the extracts and fractions obtained from 3 plants used in Nigerian ethnomedicine for malaria and
bacterial infections. The vacuum liquid chromatography of the P. nitida was done in line with standard operating procedures in pre-fractionation
technique to separate the non-polar (n-hexane), intermediate (hexane: ethylacetate), and polar (ethylacetate: methanol) compounds. We have evaluated
these extracts and fractions for activities against a panel of pathogenic fungi, bacteria, and the protozoa to explore the beneficial effects of these herbs.
Traditional herbal practitioners in Nigeria have achieved success with the use of P. nitida as remedy against malaria. Here, we report the
antiplasmodial activity of the crude extracts and VLC fractions on two strains of Plasmodium falciparum (P. falciparum D6 and P. falciparum W2).
Primary antimalarial evaluation of the methanol extract of P. nitida showed 91% growth inhibition in P. falciparum D6 clone at a concentration of
15867 µg/ml. Further evaluation of the methanol extract of P. nitida (Table 2) revealed moderate dose-dependent activity with IC50 values of 6.33
mg/ml and 6.00 mg/ml against D6 and W2 clones with a selectivity index ranging from >7.5 and >7.9, respectively. The other fractions of PNS
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showed activity against the two strains of Plasmodium falciparum. PNS1 gave a strong activity at IC50 of 3.50 and 2.82 mg/ml for D6 and W2
respectively, at a concentration of 4.70 mg/ml, and a selectivity index of >1.4 and >1.7.
Extracts obtained from P. americana and J. podagrica were also evaluated for their in vitro antimicrobial activities, and the results in Tables
3 and 4.
Table 1: Plants collection, parts tested and voucher number
Plant Voucher
specimen no.
Locality Family Part tested Extraction yield
Picralima nitida Durand
PNS1
PNS2
PNS3
PNS4
PNS5
FHI109572 Benin City Apocynaceae stem 11.25
2.23
1.45
2.23
1.08
3.45
Persea americana Mill
PASC
PARP
PAS
FHI 107767 Ovia north east local
government area,
Edo State
Lauraceae Root, seed 40.68 ( R)
5.78
2.34
12.85
Jatropha podagrica Hook FHI 93265 Owan east local
government area,
Edo State
Euphorbiaceae fruit 7.02%
Table 2: Percent Inhibitions of Persea americana and Jatropha podagrica against bacteria and fungi
Test organism % inhibition @ 50µg/mL
PARP PASC PAS JPF
C.albicans 29 55 52 0
C. glabrata 16 49 40 8
C. krusei 37 68 58 17
A. fumigatus 13 96 12 6
C.neoformans 45 100 100 82
S. aureus 35 47 21 22
MRSA 84 97 14 10
E.coli 24 40 33 23
P. aeruginosa 6 8 2 38
M.intracellulare 0 54 0 0
Table 3: Antimicrobial activities of extract and fractions of selected plants
Test organism IC50 (µg/mL) of extracts and fractions
PARP PASC PAS JPF Amphotericin
B
Ciprofloxacin
C.albicans >200 32.2 157.4 >200 0.27 NT
C. glabrata 150.9 30.6 116.5 >200 0.39 NT
C. krusei `142.2 15.5 71.1 >200 0.65 NT
A. fumigatus >200 14.7 195.1 >200 1.18 NT
C.neoformas >200 <8 8.2 16.9 0.24 NT
S. aureus 51.3 40.3 >200 >200 NT 0.12
MRSA 8.7 35.2 >200 >200 NT 0.10
E.coli >200 >200 >200 >200 NT 0.006
P. aeruginosa >200 171.3 >200 58.7 NT 0.09
M.intracellulare >200 95.7 186.1 >200 NT 0.40
NT: Not tested
The primary assay (Table 3) showed that the two plants had antifungal activity against Candida krusei (68 and 58%) and Candida albicans (55 and 52
% for JPF). These two organizms are known to contribute to opportunistic fungal infections. The antimicrobial results indicated that pet. ether
extracts of P.americana root, chloroform fraction of P. americana seed and methanol fraction of P. americana seed showed strong antifungal activity
against Candida krusei (IC50 142.20 mg/ml,15.51mg/ml and 71.10 mg/ml respectively). Previous reports had indicated that P. americana is used for
treatment of skin diseases related to fungal infections, such as white lesions of vulva, vitiligo, psoriasis, tinea capitis, and lichen amyloidosis. This
investigation provides a significant experimental evidence for development of PA as a potential antifungal agent. As well, the fraction chloroform
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extract of P. americana seed, methanol fraction of PAS and methanol fraction of JPF showed strong activity against Cryptococcus neoformans at
100,100 and 82 % inhibition with IC50 values of < 8, 8.211 and 16.93 µg/ml respectively. Only the petroleum ether of P. americana root, showed low
activity against C. neoformans at IC50 of > 200 mg/ml. PARP and PASC showed a significant activity against methicillin-resistant Staphylococcus
Table 4: Activity of P. nitida extract and fractions against Plasmodium falciparum
IC50 (µg/mL) of extracts and fractions
Extract/fractions P. falciparum
D6 IC50
P. falciparum
D6 SI
P. falciparum W2
IC50
P. falciparum
W2 SI
VERO
IC50
PNS 6331.3 >7.5 6005.6 >7.9 >47600
PNS1 >35051.8 >1.4 28376.9 >1.7 >47600
PNS2 >4760 1 >47600 1 >47600
PNS 3 >4760 1 >4760 1 >4760
PNS4 16992.1 >2.8 15902.6 >3 >4760
PNS5 >4760 1 >4760 1 >4760
aureus (IC50 8.695 mg/ml and 35.189 mg/ml respectively). All of the extracts were inactive against E. coli, PASC was the only extract active against
Mycobacterium intracellulare 54% (IC50 95.93) and Aspergillus fumigatus 96% (IC50 14.728).
Extract of P. americana exhibited significant in vitro antimicrobial activity against of microorganisms, C. neoformans, methicillin-resistant S.
aureus, E. coli, M. intracellulare, and A. fumigatus. The fractions of P. nitida, demonstrated strong in vitro antimalarial activities against chloroquine
susceptible (D6) and resistant (W2) strains of Plasmodium falciparum with IC50s ranging from 120 - 270 ng/mL.
The in vitro antibacterial assay of JPF showed complete inactivity to bacteria. A cursory electronic literature search did not reveal any
reports of signiﬁcant antibacterial activity for the fruit of J. podagrica, though the root and stems were documented to possess antibacterial activity.
Conclusion
The results indicated promising antimicrobial and antiplasmodial actions of P. americana and P. nitida. Further evaluation of in vivo
antimicrobial and antiplasmodial activities in an animal model is needed
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